Cell harvester for MB filtermat-96 well
Ended Awarded
- Contract number
- HHSN26100013
- Awardee
-
Revvity Health Sciences, Inc. UEI G2TETZJTELL4 Part of Revvity Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $17,426
Award facts
- Contract value 100% obligated
- $17,425.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
Award details come from SAM.gov/FPDS.
About this award
Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) was awarded a firm fixed-price Blanket Purchase Agreement (BPA) call valued at $17,425.93 by the National Cancer Institute (NCI) on August 10, 2017, for a cell harvester compatible with the MB FilterMat-96 well system. The contract was performed in San Diego, California, with an ultimate completion date of August 2, 2018. No small business set-aside designation was utilized for this award. The BPA call structure allowed NCI to procure specialized laboratory equipment supporting the Institute's research mission in cancer biology and related scientific investigations.
Revvity Health Sciences operates as a subsidiary of Revvity Inc. and functions as a critical supplier of advanced scientific instrumentation and laboratory equipment to federal agencies across the National Institutes of Health and other civilian research organizations. The company's broader federal portfolio encompasses medical imaging systems, cell analysis equipment, and maintenance services. This specific award represents a discrete procurement under the company's broader capability to supply specialized laboratory instrumentation required for cancer research initiatives and cell-based assays conducted by NCI-funded programs.
Quick answers
Who was awarded contract HHSN26100013?
HHSN26100013 was awarded to Revvity Health Sciences, Inc. by National Cancer Institute (National Institutes of Health) on August 10, 2017.
How much is contract HHSN26100013 worth?
The government has obligated $17,426 on HHSN26100013.
Is contract HHSN26100013 an order under another contract?
Yes. HHSN26100013 is a BPA call under HHSN263201500062B, a blanket purchase agreement.
Was contract HHSN26100013 competed?
The extent of competition for HHSN26100013 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award